Clorox Co. said its normalized net income for the fiscal third quarter ended March 31 came to $1.01 per share, compared with the S&P Capital IQ consensus estimate of $1.10 per share.
EPS declined 5.8% year over year from $1.07.
Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was $135.6 million, a decrease from $141.3 million in the prior-year period.
The normalized profit margin declined to 9.7% from 10.3% in the year-earlier period.
Total revenue climbed on an annual basis to $1.40 billion from $1.37 billion, and total operating expenses climbed year over year to $1.16 billion from $1.12 billion.
Reported net income fell from the prior-year period to $144.8 million, or $1.08 per share, from $150.0 million, or $1.14 per share.
